Cambridge Healthtech Institute

International Experts in Computational Drug Design, Genome Interpretation, and an All-Star CIO Panel Headline 2013 Bio-IT Conference in Boston

Five Visionary Keynotes to Headline the Inaugural Conference

Find Strategies to Maximize microRNA as a Target and Tool for Therapeutic Development

Utilizing Data, Moving into the New CER Reality and Overcoming Operational Challenges

Latest speaker confirmed: John S. Yu, M.D., Professor & Vice Chairman, Neurosurgery, Cedars-Sinai Medical Center; Chairman & CSO, ImmunoCellular Therapeutics

CHI's Evidence-Based Reimbursement Summit well positioned to cover the recent CPT Code Changes enacted by the AMA. Features dedicated presentations on the effect these changes will have on Medicare, Medicaid, as well as private insurances policies.

Deploying Information Technology to Enable Innovation within the Future State of Care: Connecting Patients, Providers, and Payers

CHI’s Oncology Clinical Trials: Bringing Effective and Safe Cancer Therapy to Patient takes place Feb. 13-15, 2013 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Molecular Med TRI-CON 2013.

Cambridge Healthtech Institute's inaugural Evidence-Based Reimbursement Summit is being held November 5-7, 2012 in Philadelphia, PA. Will feature Generating Evidence for Reimbursement Decisions: Therapeutics and Diagnostics.

The Fourth Annual Leaders in Biobanking Congress is only three weeks away! Don’t miss this record breaking event!